Pertussis (Whooping Cough) - Pipeline Review, H2 2016 - Strenghtens R&D Pipelines by Identifying New Targets & MOAs - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Pertussis (Whooping Cough) - Pipeline Review, H2 2016" report to their offering.

Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes and dry cough. Treatment includes antibiotics.

This report provides comprehensive information on the therapeutic development for Pertussis (Whooping Cough), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pertussis (Whooping Cough) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned

  • Beijing Minhai Biotechnology Co Ltd
  • Beijing Tiantan Biological Products Co Ltd
  • Bharat Biotech International Ltd
  • Biken Inc
  • Biological E Ltd
  • Boryung Pharmaceutical Co Ltd
  • Daiichi Sankyo Company Ltd
  • DBV Technologies SA
  • GlaxoSmithKline Plc
  • Green Cross Corp
  • ILiAD Biotechnologies LLC
  • Indian Immunologicals Ltd
  • Kaketsuken KK
  • LG Life Science LTD
  • NanoBio Corp
  • Panacea Biotec Ltd
  • Sanofi Pasteur SA
  • Serum Institute of India Ltd
  • Shantha Biotechnics Ltd
  • Synthetic Biologics Inc
  • Zydus Cadila Healthcare Ltd

Key Topics Covered:

  1. Introduction
  2. Pertussis (Whooping Cough) Overview
  3. Therapeutics Development
  4. Pipeline Products for Pertussis (Whooping Cough) - Overview
  5. Pipeline Products for Pertussis (Whooping Cough) - Comparative Analysis
  6. Pertussis (Whooping Cough) - Therapeutics under Development by Companies
  7. Pertussis (Whooping Cough) - Therapeutics under Investigation by Universities/Institutes
  8. Pertussis (Whooping Cough) - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Pertussis (Whooping Cough) - Products under Development by Companies
  13. Pertussis (Whooping Cough) - Products under Investigation by Universities/Institutes
  14. Pertussis (Whooping Cough) - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/75czl6/pertussis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs